Navigation Links
Good vibrations: Using light-heated water to deliver drugs
Date:4/1/2014

Researchers from the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, in collaboration with materials scientists, engineers and neurobiologists, have discovered a new mechanism for using light to activate drug-delivering nanoparticles and other targeted therapeutic substances inside the body.

This discovery represents a major innovation, said Adah Almutairi, PhD, associate professor and director of the joint UC San Diego-KACST Center of Excellence in Nanomedicine. Up to now, she said, only a handful of strategies using light-triggered release from nanoparticles have been reported.

The mechanism, described in the April 1, 2014 online issue of ACS Nano, employs near-infrared (NIR) light from a low-power laser to heat pockets of water trapped within non-photo-responsive polymeric nanoparticles infused with drugs. The water pockets absorb the light energy as heat, which softens the encapsulating polymer and allows the drug to be released into the surrounding tissue. The process can be repeated multiple times, with precise control of the amount and dispersal of the drug.

"A key advantage of this mechanism is that it should be compatible with almost any polymer, even those that are commercially available," said Mathieu Viger, a post-doctoral fellow in Almutairi's laboratory and co-lead author of the study. "We've observed trapping of water within particles composed of all the biodegradable polymers we've so far tested."

The method, noted Viger, could thus be easily adopted by many biological laboratories.

The combined use of hydrated polymers and near-infrared light appears to resolve a host of technological and health barriers that have hindered previous, similar approaches. Earlier efforts to use NIR-triggered release have not been widely exploited because they required special designer polymers, expensive high-powered lasers and/or the co-encapsulation of inorganic part
'/>"/>

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Using your loaf to fight brain disease
2. Inhibition of oral biofilm and cell-cell communication using natural-products derivatives
3. CWRU researchers find byproducts of bacteria-causing gum disease incite oral cancer growth
4. Tumors light up with new, unique imaging system using scorpion venom protein and a laser
5. Obesity treatment using stem cells is the topic of 2013s most-visited news release on EurekAlert!
6. Using susceptibility-weighted imaging to study concussion in college ice hockey players
7. New biomedical diagnostics using personalized 3-D imaging
8. Vulvar condition causing painful sex strikes twice as many Hispanic women
9. Enhancing bioavailability of healthful components in food using nanoparticle design
10. Helping Children with Autism Using Brain Training Apps from C8 Sciences
11. Viral microRNAs responsible for causing AIDS-related cancer, new USC study shows
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Good vibrations: Using light-heated water to deliver drugs
(Date:3/30/2015)... V/NO (Virtually No Alcohol) Wines have a ... opening/closing and for reuse. Consumers simply twist the cup, turn ... Yorkers, professionals, and basically anyone can now enjoy a ... back socially or pair with meals at work, home, or ... wine and that means Napa Wine grapes undergo the ...
(Date:3/30/2015)... 30, 2015 South Coast Surety is pleased ... Bond Representative. Richard has been known to the management of ... Richard attended the University of Georgia, majoring in Banking and ... the sales and sales management of business equipment for a ... Most recently, Richard was a senior officer with a National ...
(Date:3/30/2015)... 30, 2015 Considered to be the ... in the global business community, this next generation of ... ante by managing big data and frameworks with virtually ... already powerful analytic and logic features are a technological ... of Lazarus Alliance said “The IT Audit Machine is ...
(Date:3/30/2015)... GREEN, Ohio (PRWEB) March 30, 2015 ... a globally recognized designer and manufacturer of ... and vinyl upholstery options. The new upholsteries ... laboratory, education and custom seating, providing disinfectable, ... are manufactured by renowned textile purveyor CF ...
(Date:3/29/2015)... 2015 Pro Ace Care Heating & ... now provide qualified HVAC technicians that will visit the ... and related systems throughout Vancouver, North Vancouver, Burnaby, Richmond, ... conditioners, heat pumps require regular maintenance from a professional. ... BC Hydro strongly suggest you have it serviced annually ...
Breaking Medicine News(10 mins):Health News:Napa Valley Alcohol-Removed Red, White & Rosé Wines Have Launched. 2Health News:Richard Ford Joins South Coast Surety Contract Surety Team 2Health News:Building on Success: Next Generation of Cyber Crime Prevention Unveiled! 2Health News:BioFit Adds Bleachable Upholstery Options to Seating Line 2Health News:Pro Ace Care Now Provides Qualified HVAC Technicians for Heat Pump Maintenance 2
... , , Mr. Randall Terry and ... city tour, where they held press conferences, performed street theatre, and ... HR 3200. More Details and links at www.OverturnRoe.com , , ... by Randall Terry, founder of Operation Rescue. , , ...
... WASHINGTON, Aug. 26 Loretta King, Acting Assistant Attorney General ... a federal grand jury in Denver has charged Donald Hertz ... the Freedom of Access to Clinic Entrances (FACE) Act for ... The FACE Act makes it a federal crime to injure, ...
... gut noted in study of people with type 1 version ... abnormal immune response to wheat proteins may contribute to type ... people with type 1 diabetes found that nearly half had ... identified genes associated with this abnormal immune response. , "The ...
... genes that may contribute to drug resistance in non-small ... in the open access journal BMC Cancer ... in drug sensitivity and resistance and actual in vitro ... UK, led a team of researchers who assessed the ...
... ... Association (DIA), in cooperation with FDA and PhRMA, will host Progression-Free Survival Oncology Workshop ... ... Drug Information Association (DIA), in cooperation with FDA and PhRMA, will host ...
... , INDIANAPOLIS, Aug. 26 ... gaming interests reported more than $3.6 million in lobbying expenditures ... Indiana public records. , , Individuals employed ... giving more than $228,000 to state political party committees and ...
Cached Medicine News:Health News:Randall Terry, Abortion, and Health Care: Terry comments on disruption of 'Health Care' Town Hall meeting. 'Yes: We disrupted Howard Dean's speech, and we would do it again. Obama and Pelosi must write into the bill: "No Abortion Funding; No mandates for 2Health News:DIA/FDA/PhRMA to Host Progression-Free Survival Oncology Workshop 2Health News:DIA/FDA/PhRMA to Host Progression-Free Survival Oncology Workshop 3Health News:The Gaming Industry Stacks the Deck Against Smokefree Workplaces in Indiana 2
(Date:3/30/2015)... , March 30, 2015  BioDelivery Sciences ... the primary efficacy endpoint in the Phase 3 ... placebo for the treatment of painful diabetic neuropathy ... endpoints showed statistically significant improvement over placebo.  In ... was observed.  The results of this trial provide ...
(Date:3/29/2015)... TITUSVILLE, N.J. , March 29, 2015 /PRNewswire/ ... delayed time to relapse compared to placebo in ... 3 clinical study published this week in the ... (JAMA) Psychiatry . Results of ... recent New Drug Application (NDA) filing for three-month ...
(Date:3/27/2015)... /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") ... the issuance of an aggregate of 30,000 stock options ... aggregate of 120,500 stock options to employees and consultants ... three years and will be exercisable for a period ... per stock option. About Covalon Covalon ...
Breaking Medicine Technology:BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 2BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 3BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 4BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 2New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 3New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 4New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 5New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 6New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 7New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 8New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 9New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 10New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 11New Study Published in JAMA Psychiatry Found Three-Month Paliperidone Palmitate Significantly Delayed Time to Relapse in Patients with Schizophrenia 12Covalon Announces Issuance of Stock Options 2
... Sequella, Inc., a clinical-stage biopharmaceutical company focused on ... announced that it received a $694,000 grant supplement as ... of 2009. The ARRA funds, issued through the National ... National Institute of Health (NIH), will assist Sequella to ...
... Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical ... ) focused on bringing the life saving potential ... nationwide and internationally, said today that it has retired ... of $212,959, $250,000 and $285,000. , On October 2, ...
Cached Medicine Technology:Sequella Receives American Recovery and Reinvestment Funding Through the NIH 2Cord Blood America Continues to Reduce Debt; Three Notes Retired 2
Implex cemented hip stem....
Stability cemented stem....
Porous foundation 440 series....
Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Medicine Products: